Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHIO PHARMACEUTICALS CORP.

(PHIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization1 5,996,3015,524,8-
Entreprise Value (EV)1 5,996,3015,524,824,8
P/E ratio -0,32x-0,49x-1,40x-1,66x1,83x
Yield -----
Capitalization / Revenue 43,4x300x--0,50x
EV / Revenue 43,4x300x--0,50x
EV / EBITDA -----
Price to Book -----
Nbr of stocks (in thousands) 3306695 78113 534-
Reference price (USD) 18,19,412,691,831,83
Announcement Date 03/27/201903/26/202003/25/2021--
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022
Net sales1 0,140,02--50,0
EBITDA -----
Operating profit (EBIT)1 -7,36-8,99-8,79-14,335,0
Operating Margin -5 336%-42 795%--70,0%
Pre-Tax Profit (EBT)1 -7,36-8,91-8,79-14,135,0
Net income1 -7,36-8,91-8,79-14,126,6
Net margin -5 333%-42 419%--53,2%
EPS2 -57,2-19,3-1,92-1,101,00
Dividend per Share -----
Announcement Date 03/27/201903/26/202003/25/2021--
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -2,31-2,46--3,60-3,40-3,70
Operating Margin ------
Pre-Tax Profit (EBT)1 -2,31-2,46--3,60-3,40-3,70
Net income1 -2,31-2,46--3,60-3,40-3,70
Net margin ------
EPS2 -0,40-0,41-0,32-0,26-0,25-0,28
Dividend per Share ------
Announcement Date 11/10/202003/25/202105/13/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt -----
Net Cash position -----
Leverage (Debt / EBITDA) -----
Free Cash Flow -----
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex -----
Capex / Sales -----
Announcement Date 03/27/201903/26/202003/25/2021--
1 USD in Million
Key data
Capitalization (USD) 24 767 931
Number of employees 10
Free-Float 99,7%
Free-Float capitalization (USD) 24 696 480
Avg. Exchange 20 sessions (USD) 691 462
Average Daily Capital Traded 2,79%
EPS & Dividend
Change in Enterprise Value/EBITDA